Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

Shares of MBX Biosciences, Inc. (NASDAQ:MBX) rose sharply in pre-market trading after the company announced that it will provide topline results from its Phase 2 clinical trial of potential once-weekly canvuparatide for patients with chronic hypoparathyroidism on Sep. 22.

MBX Biosciences shares jumped 28.2% to $12.87 in the pre-market trading session.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.